Lobbying Information
Subject Matters
- Aboriginal Affairs
- Agriculture
- Consumer Issues
- Economic Development
- Health
- Industry
- International Trade
- Justice and Law Enforcement
- Regional Development
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- To advocate for investment from the government into medical cannabis production expansion in key regions and the resulting job creation.
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
- Advocacy related to Bill C-45, "An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts" to advocate for a strong, well-regulated recreational cannabis system that allows for limited branding/in-store promotion and fair taxation for legal cannabis producers while meeting the federal goals of keeping cannabis out of the hands of children, eradicating the black market, minimizing harms of use, ensuring Canadians are well-informed about responsible use and, establishing and enforcing a system of strict production and distribution while continuing to provide medical cannabis to patients in need.
- Advocacy related to Bill C-46, "An Act to amend the Criminal Code (offences relating to conveyances) and to make consequential amendments to other Acts", to ensure that provisions contained in the legislation protect the public health of Canadians, including active medical cannabis patients.
Policies or Program
- Advocacy related to the development of an export strategy for medical cannabis to ensure that Canada's licensed producers are able to seize first-mover advantage in international medical cannabis markets.
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Canada Revenue Agency (CRA)
-
Canadian Heritage (PCH)
-
Employment and Social Development Canada (ESDC)
-
Farm Credit Canada (FCC)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
Justice Canada (JC)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Safety Canada (PS)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
-
Veterans Affairs Canada (VAC)
-
Western Economic Diversification Canada (WD)
In-house Corporation Details
Description of activities
Privateer Holdings is a private equity firm focused on the future of the legal cannabis industry. Through a combination of acquisitions, investments and incubation, we are building a portfolio of global brands that will lead, legitimize and define the future of cannabis.
Responsible officer name and position during the period of this registration
Brendan Kennedy,
Chief Executive Officer
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
1920 Eastlake Avenue E
Seattle, WA 98102
United States of America
Telephone number:
415-534-5541
Parent Company Information
Privateer Holdings is not a subsidiary of any other parent companies.
Subsidiary Beneficiary Information
- Leafly
-
71 Columbia Street
Suite 300
Seattle, WA 98104
United States of America
- Marley Natural
-
1920 Eastlake Ave E.
Seattle, WA 98102
United States of America
- Tilray
-
1100 Maughan Road
Nanaimo, BC V9X 1J2
Canada
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Caleb Eades,
Chief Science Officer & Vice President |
No public offices held
- Zack Hutson,
Vice President of Corporate Affairs |
No public offices held
- Brendan Kennedy,
Chief Executive Officer |
No public offices held
- Woody Pastorius,
President, Tilray North America |
No public offices held
- Christy Zhou,
General Counsel (Tilray) |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties